Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This randomized, open label study will evaluate a nurse and pharmacist led clinic conducted remotely from Grand River Regional Cancer Centre at Grand River Hospital (GRRCC/GRH) using OTN teleconferencing as a platform for patients with prostate cancer receiving oral chemotherapy agents.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| OTN virtual clinic | Experimental | Pharmacist and nurse led OTN based remote teleconference based clinic (OTN) The OTN clinic will be conducted by providing the patient with a link via email which will allow the patient to access OTN teleconferencing and meet virtually with a pharmacist and nurse during a previously scheduled appointment. Virtual clinic appointments will be 30 minutes long and will consist of a patient assessment and open ended questions about the patient health status using a modified version of the validated MOATT (MASCC Oral Agent Teaching Tool) created by the Multidisciplinary Association of Supportive Care in Cancer. |
|
| In person Visits | No Intervention | Patients are followed in person at the cancer clinic based on standard of care guidelines |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Visits conducted via Telemedicine | Other | Patients will be followed via telemedicine with visits lead by a Pharmacist and a Nurse |
|
| Measure | Description | Time Frame |
|---|---|---|
| Patient satisfaction with overall care | The primary outcome will be a comparison of patient satisfaction with overall care utilizing a validated scale between the group of patients using the OTN clinic and a group of control patients receiving conventional care at GRRCC | 2 Years |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Patients receiving oral anti-cancer therapy other than abiraterone and enzalutamide.
Patients lacking the technology at home to participate in the virtual telemedicine clinic. (excluding control group)
-
Prostate Cancer Patients
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Stacey Hubay, MD, FRCPC | Contact | 519-749-4370 | 2307 | stacey.hubay@grhosp.on.ca |
| Carla Girolametto, MA, MHSC | Contact | 519-749-4370 | 2307 | carla.girolametto@grhosp.on.ca |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Grand River Hospital | Recruiting | Kitchener | Ontario | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016609 | Neoplasms, Second Primary |
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided